Bispecific Antibodies Treat Cancer in Mouse Models
Bispecific Antibodies Treat Cancer in Mouse Models
A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.
Bispecific Antibodies Treat Cancer in Mouse Models
Bispecific Antibodies Treat Cancer in Mouse Models

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

  1. Home
  2. Subjects
  3. immunotherapy
immunotherapy
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 5, 2021
Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.
Cancer Vaccines: Raising a T Cell Army
Cancer Vaccines: Raising a T Cell Army
The Scientist Creative Services Team | Apr 1, 2021
Vaccines against various forms of cancer prime the immune system to attack.
Surveillance Gaps: How Cancer Arises
Surveillance Gaps: How Cancer Arises
The Scientist Creative Services Team | Mar 15, 2021
Surveillance Gaps: How Cancer Arises
Fecal Transplant Could Boost Immunotherapy to Treat Melanoma
Fecal Transplant Could Boost Immunotherapy to Treat Melanoma
Shawna Williams | Feb 12, 2021
The results from two Phase 1 trials bolster the case that the gut microbiome plays a role in response to the drugs.
The Scientist Speaks Podcast - Episode 10
The Scientist Speaks Podcast - Episode 10
The Scientist Creative Services Team | Oct 28, 2020
Cancer Immunotherapy: CRISPR Reveals Targets In Vivo
Longitudinal Immune Profiling Reveals Key Immune Signatures Associated with COVID-19
Longitudinal Immune Profiling Reveals Key Immune Signatures Associated with COVID-19
The Scientist Creative Services Team | Sep 14, 2020
Madhvi Menon will discuss immune profiling of COVID-19 patients and Jyoti Phatak-Sheldon will highlight the use of RNAscope in situ hybridization in SARS-CoV-2 research.
Infographic: How Immunotherapy Could Boost Stem-Like T Cells
Infographic: How Immunotherapy Could Boost Stem-Like T Cells
Daniel E. Speiser and Werner Held | Jul 13, 2020
Cancer therapies could potentially be more effective if their development took into account the cells that give rise to tumor-fighting cells.
Contributors
Contributors
The Scientist Staff | Jul 13, 2020
Meet some of the people featured in the July/August 2020 issue of The Scientist.
Harnessing Stem Cell–Like T Cells to Better Fight Cancer
Harnessing Stem Cell–Like T Cells to Better Fight Cancer
Daniel E. Speiser and Werner Held | Jul 13, 2020
Better understanding the CD8+ T cells already present in tumors could be key to making immunotherapies work for more patients.